Category Cardiovascular

Diagnosis and management of concurrent cardiac disease: Coronary disease, dilated ascending aorta, and mitral and tricuspid valve disease

Coronary artery disease Prevalence and clinical impact In randomized clinical trials, more than two-thirds of intermediate- and high-risk transcatheter aortic valve implantation (TAVI) candidates have coronary artery disease (CAD). , The impact of CAD on long-term outcomes after TAVI is…

Preprocedural imaging

Introduction The importance of precise preprocedural multimodality imaging with echocardiography and cardiac multislice computed tomography (MSCT) before transcatheter aortic valve implantation (TAVI) cannot be overemphasized. Both echocardiography and MSCT imaging are the foundations of quality outcomes in TAVI and are…

Patient selection

Introduction The following prerequisites are essential before patient selection in transcatheter aortic valve intervention (TAVI): 1. An accurate diagnosis of severe aortic stenosis (AS) 2. An indication for aortic valve intervention (i.e., severe symptomatic AS) 3. A constellation of clinical,…

Volume and Outcome

Key Points An inverse relationship between experience and outcome for higher-risk procedures has been repeatedly demonstrated over the past 30 years. In the case of percutaneous coronary angioplasty, the minimum volume thresholds involve low numbers of fewer than four cases…